Feature|Articles|March 1, 2024
- Hennessy's Highlights® March 2024
- Volume eBook
Download Hennessy's Highlights® March 2024 edition
Click the title above for a link to open the eBook in a PDF format.
Advertisement
Hennessy's Highlights® features the latest oncology news From Mike Hennessy Jr, President & CEO of MJH Life Sciences.
The March 2023 issue, available for download below, contains:
- Early Phase Clinical Research Center Poised to Provide New Benefits in Hawaii and Beyond
- Outreach and Engagement: Colleagues Come Together to Improve Community Care
- Tampa General Hospital Cancer Institute Celebrates 2 Years of Growth and Innovation
- Metrics Report: Which of Your Peers Are Trending?
Articles in this issue
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
5
